UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Effects of vedolizumab in Japanese patients with Crohn’s disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses

Journal of gastroenterology, 2020-03, Vol.55 (3), p.291-306

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study

Hypertension research, 2012-05, Vol.35 (5), p.552-558

2012

Link zum Volltext

Verfügbarkeit prüfen

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

PloS one, 2019-02, Vol.14 (2), p.e0212989-e0212989

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study

Clinical and experimental nephrology, 2022-04, Vol.26 (4), p.350-358

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study

Clinical and experimental nephrology, 2022-04, Vol.26 (4), p.359-359

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma

International journal of clinical oncology, 2022-01, Vol.27 (1), p.224-233

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

PloS one, 2019-04, Vol.14 (4), p.e0215491-e0215491

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial

Vaccine, 2022-05, Vol.40 (24), p.3380-3388

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial

Vaccine, 2024-01, Vol.42 (3), p.662-670

2024

Link zum Volltext

Verfügbarkeit prüfen

A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report

Vaccine, 2022-03, Vol.40 (13), p.2044-2052

2022

Link zum Volltext

Verfügbarkeit prüfen

One-year follow-up of the immunogenicity and safety of a primary series of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Final report of a phase I/II randomized controlled trial

Vaccine, 2024-02, Vol.42 (6), p.1319-1325

2024

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial

Vaccine, 2023-06, Vol.41 (25), p.3763-3771

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open-label study

Journal of dermatology, 2023-11, Vol.50 (11), p.1473-1477

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of a 60-week treatment with candesartan in Japanese patients with mild to moderate chronic heart failure

Journal of cardiology, 2013-04, Vol.61 (4), p.267-274

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study

Advances in therapy, 2023-06, Vol.40 (6), p.2902-2914

2023

Link zum Volltext

Verfügbarkeit prüfen

Tu1746 – A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderate to Severe Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1109-S-1109

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension

Blood pressure monitoring, 2014-06, Vol.19 (3), p.164

2014

Link zum Volltext

Verfügbarkeit prüfen

Theoretical Basis of Adaptive Designs for Clinical Trials in Phase II and III

Japanese Journal of Biometrics, 2008/07/01, Vol.29(Special_Issue_1), pp.S33-S52

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus

Current medical research and opinion, 2011-11, Vol.27 (S3), p.73-84

2011

Link zum Volltext

Verfügbarkeit prüfen

A multicenter, phase III evaluation of the efficacy and safety of a new fixed-dose pioglitazone/glimepiride combination tablet in Japanese patients with type 2 diabetes

Diabetes technology & therapeutics, 2013-02, Vol.15 (2), p.158

2013

Link zum Volltext

Verfügbarkeit prüfen

Identification of Epistatic Interactions Involved in Non-Insulin-Dependent Diabetes Mellitus in the Otsuka Long-Evans Tokushima Fatty Rat

Experimental Animals, 2001, Vol.50(2), pp.115-123

2001

Link zum Volltext

Verfügbarkeit prüfen

Mapping and characterization of quantitative trait loci for non-insulin-dependent diabetes mellitus with an improved genetic map in the Otsuka Long-Evans Tokushima fatty rat

Mammalian genome, 1999-03, Vol.10 (3), p.249-258

1999

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel non-insulin-dependent diabetes mellitus susceptibility loci in the Otsuka Long-Evans Tokushima Fatty rat by MQM-mapping method

Mammalian genome, 1999-12, Vol.10 (12), p.1126-1131

1999

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin II Type 1a Receptor-deficient Mice with Hypotension and Hyperreninemia (∗)

The Journal of biological chemistry, 1995-08, Vol.270 (32), p.18719-18722

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of vedolizumab in Japanese patients with Crohn’s disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses

Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study

Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study

A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma

Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

Japan PGx Data Science Consortium Database: SNPs and HLA genotype data from 2994 Japanese healthy individuals for pharmacogenomics studies

Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial

Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial

A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report

One-year follow-up of the immunogenicity and safety of a primary series of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Final report of a phase I/II randomized controlled trial

Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial

Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open-label study

Efficacy and safety of a 60-week treatment with candesartan in Japanese patients with mild to moderate chronic heart failure

Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study

Tu1746 – A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderate to Severe Crohn's Disease

Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension

Theoretical Basis of Adaptive Designs for Clinical Trials in Phase II and III

Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus

A multicenter, phase III evaluation of the efficacy and safety of a new fixed-dose pioglitazone/glimepiride combination tablet in Japanese patients with type 2 diabetes

Identification of Epistatic Interactions Involved in Non-Insulin-Dependent Diabetes Mellitus in the Otsuka Long-Evans Tokushima Fatty Rat

Mapping and characterization of quantitative trait loci for non-insulin-dependent diabetes mellitus with an improved genetic map in the Otsuka Long-Evans Tokushima fatty rat

Identification of novel non-insulin-dependent diabetes mellitus susceptibility loci in the Otsuka Long-Evans Tokushima Fatty rat by MQM-mapping method

Angiotensin II Type 1a Receptor-deficient Mice with Hypotension and Hyperreninemia (∗)

Suchergebnisse filtern